The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin. [electronic resource]
Producer: 20200221Description: 1245-1256 p. digitalISSN:- 1095-8355
- Bone Neoplasms -- metabolism
- Cell Line, Tumor
- Cisplatin -- therapeutic use
- Drug Resistance, Neoplasm -- drug effects
- Ferroptosis -- drug effects
- Humans
- NF-E2-Related Factor 2 -- metabolism
- Osteosarcoma -- metabolism
- Phospholipid Hydroperoxide Glutathione Peroxidase -- metabolism
- Piperazines -- pharmacology
- STAT3 Transcription Factor -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.